TY - JOUR
T1 - Real World Outcomes of First Line Pertuzumab Based Therapy in HER2 Positive Metastatic Breast Cancer: Performance Status, Metastatic Burden and Nutritional Status as Prognostic Factors
Y1 - 2026
PY - 2026
DA - 2026
N1 - doi:2612459
T2 - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JF - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JO - EJMI
SP - 459
EP - 472
VL - 10
IS - 4
SN - 
M3 - doi:2612459
UR - https://dx.doi.org/10.14744/ejmi.2612459
Y2 - 2026
ER -